NCT06917664View on ClinicalTrials.gov

Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

PHASE4RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Coronary Artery DiseaseIschemic Mitral RegurgitationAngiotensin Receptor/Neprilysin Inhibitor
Interventions
DRUG

sacubitril/valsartan

Sacubitril/valsartan therapy after isolated CABG

Trial Locations (1)

100037

RECRUITING

China National Center for Cardiovascular Diseases, Beijing

All Listed Sponsors
collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

collaborator

Chinese Academy of Medical Sciences

OTHER

lead

China National Center for Cardiovascular Diseases

OTHER_GOV